-
UniQure Secures Type A Meeting with FDA: What This Means for AMT-130
Latest News
-
Putting Huntington’s disease medications to the test: results from the Neuro-HD trial
⏱️6 min read | A clinical trial, Neuro-HD, compared 3 common drugs for HD symptoms. The 1 year study found no “best” medication, but clear differences between treatments. The results support a personalised, symptom-by-symptom approach to HD treatment.
-
Video: What’s new in Huntington's disease research 2012
Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss
-
Shooting the messenger with single-stranded RNA gene silencing
New ‘single-stranded RNA’ gene silencing drugs could be safer & more effective to treat Huntington’s disease
-
EuroBuzz Video: Day 2
Watch the full video of EuroBuzz day 2 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
-
EuroBuzz Video: Day 1
Watch the full video of EuroBuzz day 1 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
-
EuroBuzz News: Day 3
EuroBuzz news: Day 3. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm
-
EuroBuzz News: Day 2
EuroBuzz news: Day 2. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm
-
EuroBuzz News: Day 1
EuroBuzz news: Day 1. Ed and Jeff reporting from the European Huntington’s Disease Network meeting in Stockholm
-
Coming Soon: EuroBuzz 2012
Coming soon from the Euro-HD Network Meeting in Stockholm: EuroBuzz!
-
Lithium with a twist gets second chance for HD
Lithium gets a second chance in HD – with a new chemical delivery method, tested in Huntington’s disease mice
-
High-power brain scans reveal sodium changes in HD
A new brain scanning technique reveals high sodium levels in HD brains. How might this help clinical trials?
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
